Description

Hizentra is a subcutaneous immunoglobulin therapy used to treat primary immunodeficiency disorders. It helps to boost the immune system by providing antibodies that the body may not produce adequately on its own.

Interpreter Notes

Interpreters should be aware that Hizentra may be referred to in various ways, but it is important to use the canonical term in formal contexts. Avoid colloquial terms that may not be recognized in clinical settings. Ensure clarity when discussing the administration route, as it can be confused with intravenous immunoglobulin therapies.

Example Sentences

EN: The patient has been prescribed Hizentra to manage their immunodeficiency.

ES: Al paciente se le ha recetado Hizentra para manejar su inmunodeficiencia.

Common Interpreter Mistakes

Confusing Hizentra with intravenous immunoglobulin; mispronouncing Hizentra as 'Hizentra'; using informal terms instead of the canonical term.